Profile image
Story Views

Last Hour:
Last 24 Hours:

Tumour Ablation Devices Market by Treatment & Data Validation, Analysis and Forecast 2022

Tuesday, February 21, 2017 11:00
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Global Tumor Ablation Devices market is estimated at $260.60 million in 2015 and is expected to grow at a CAGR of 14.6% to reach $676.66 million by 2022. . Rising incidences of cancers, technological advancements, growing aged population, rising numbers of hospitals and healthcare awareness are the key factors driving the market growth. However, negative effects related to ablation treatment and inadequate performance of the devices is hampering the market.
Radiofrequency commanded the technology segment in 2015 owing to its prominent application in solid tumor elimination in the body. On the contrary, microwave ablation technology is expected to observe remunerative growth during the predicted period due to advantages offered by this technology. Surgical procedures segment held major share of around 40% in 2015. However, percutaneous procedures are anticipated to observe productive growth over the forecast period owing to increasing demand for minimally invasive procedures offering sooner recovery and improved safety. The Asia-Pacific market is anticipated to grow at a faster pace during the forecast period owing to factors such as huge population with the high incidence of various cancers in the region.

 For more information

Some of the key players in the global Tumor Ablation Devices market are Alpinion Medical Systems Co., Ltd., Angiodynamics, Baylis Medical, biolitec AG, Biotronic NeuroNetwork, LLC, Boston Scientific Corporation , EDAP TMS S.A, Galil Medical, Inc., HealthTronics , Hironic Co., Ltd., Medtronic Plc. (Covidien), Mermaid Medical A/S, Misonix, Inc., Monteris Medical, Inc, Neuwave Medical Inc. , Perseon, Sonacare Medical, LLC, Spectranetics, St. Jude Medical, Inc., and Symple Surgical Inc. 
Products Covered:
- Thermal 
- Radiation Devices 
- High intensity focused ultrasound ablation Devices 
- Laser ablation Devices 
- Microwave ablation Devices 
- Radiofrequency ablation Devices 
- Non-Thermal 
- Cryo ablation Devices 
- Hydromechanical Devices 
- Other Ablation devices 
Treatments Covered:
- Laparoscopic Ablation 
- Surgical Ablation 
- Percutaneous Ablation 
Applications Covered:
- Bone Cancer 
- Breast Cancer 
- Colorectal Cancer 
- Kidney Cancer 
- Liver Cancer 
- Lung Cancer 
- Prostate Cancer 
- ENT cancer 
- Other Cancers 
End User’s Covered:
- Hospitals
- Ambulatory Surgical Centers

Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK 
- Spain 
- Rest of Europe 
- Asia Pacific
- Japan 
- China 
- India 
- Australia 
- New Zealand 
- Rest of Asia Pacific 
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt


Request Sample Copy


11 Company Profiling 
11.1 Alpinion Medical Systems Co., Ltd. 
11.2 Angiodynamics 
11.3 Baylis Medical, biolitec AG 
11.4 Biotronic NeuroNetwork, LLC 
11.5 Boston Scientific Corporation 
11.6 EDAP TMS S.A 
11.7 Galil Medical, Inc. 
11.8 HealthTronics 
11.9 Hironic Co., Ltd. 
11.10 Medtronic Plc. (Covidien) 
11.11 Mermaid Medical A/S 
11.12 Misonix, Inc. 
11.13 Monteris Medical, Inc 
11.14 Neuwave Medical Inc. 
11.15 Perseon 
11.16 Sonacare Medical, LLC 
11.17 Spectranetics 
11.18 St. Jude Medical, Inc. 
11.19 Symple Surgical Inc. 

Make an enquiry:

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.